Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...

Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to ...

Scientists are turning a stubborn waste problem from the beer industry into a surprisingly effective tool for making ...

Coherus Oncology, Inc. ( CHRS) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 1:30 PM EST Good morning everyone. It's still the morning. Thanks for joining us for another session at ...

For decades, depression treatment has focused almost entirely on the brain, with drugs designed to tweak neurotransmitters like serotonin and dopamine. Now a wave of research is pointing to an ...

Every time our body encounters a new disease-causing agent, a crucial defense system called adaptive immunity comes into play ...

Researchers have developed a way to 3D print custom micrometer-sized structures directly into the interior of living cells.

Scientists have uncovered a new way embryonic cells divide when conventional mechanisms fail. Cell division underpins all ...

Learning doesn’t always mean flipping through heavy textbooks or sitting in a long lecture. Sometimes, it just takes ...

The protein called intelectin-2 plays another important role by reinforcing the protective mucus layer that lines the ...